ADRA1A and prostate cancer: This aligns with recent studies that demonstrate that α1-adrenoreceptor under-expression in hepatocellular carcinoma, both through micro-RNA silencing [56] and promoter hypermethylation [57], influences tumor development and that ADRA1A downregulation in the prostate highly correlates with a prostate cancer diagnosis [58].